NBTXR3-话题@MedSci - 梅斯（MedSci）

#NBTXR3#

4篇内容 | 1137人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1940236, encodeId=45ed1940236ba, content=<a href='/topic/show?id=bec512565e6' target=_blank style='color:#2F92EE;'>#NBTXR3#</a>, objectTitle=NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患者招募, objectType=article, longId=738601, objectId=0e2de3860180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e2de3860180, replyNumber=0, likeNumber=88, createdTime=2023-03-01, rootId=0, userName=mei531, userId=7fbd46, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e2de3860180, moduleTitle=NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患者招募, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0e2de3860180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1940235, encodeId=c0c6194023516, content=<a href='/topic/show?id=bec512565e6' target=_blank style='color:#2F92EE;'>#NBTXR3#</a>, objectTitle=Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究, objectType=article, longId=207381, objectId=313020e38117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313020e38117, replyNumber=0, likeNumber=55, createdTime=2022-01-21, rootId=0, userName=mei531, userId=7fbd46, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313020e38117, moduleTitle=Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=313020e38117)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1940234, encodeId=a4ea194023479, content=<a href='/topic/show?id=bec512565e6' target=_blank style='color:#2F92EE;'>#NBTXR3#</a>, objectTitle=Lancet Oncol：首创新药氧化铪纳米颗粒NBTXR3可以提高新辅助放疗治疗局部晚期软组织肉瘤的疗效, objectType=article, longId=175185, objectId=ed911e5185bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed911e5185bf, replyNumber=0, likeNumber=84, createdTime=2019-09-12, rootId=0, userName=mei531, userId=7fbd46, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed911e5185bf, moduleTitle=Lancet Oncol：首创新药氧化铪纳米颗粒NBTXR3可以提高新辅助放疗治疗局部晚期软组织肉瘤的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ed911e5185bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1940233, encodeId=fc0819402332f, content=<a href='/topic/show?id=bec512565e6' target=_blank style='color:#2F92EE;'>#NBTXR3#</a>, objectTitle=2018年欧洲肿瘤内科学会：NBTXR3在软组织肉瘤中的阳性结果, objectType=article, longId=151530, objectId=203c15153098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=203c15153098, replyNumber=0, likeNumber=70, createdTime=2019-03-07, rootId=0, userName=mei531, userId=7fbd46, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=203c15153098, moduleTitle=2018年欧洲肿瘤内科学会：NBTXR3在软组织肉瘤中的阳性结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=203c15153098)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NBTXR3

2020-05-29

mei531 (审核中...)

前往app查看评论内容

#NBTXR3#

NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患者招募

2023-03-01

mei531 (审核中...)

前往app查看评论内容

#NBTXR3#

Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究

2022-01-21

mei531 (审核中...)

前往app查看评论内容

#NBTXR3#

Lancet Oncol：首创新药氧化铪纳米颗粒NBTXR3可以提高新辅助放疗治疗局部晚期软组织肉瘤的疗效

2019-09-12

mei531 (审核中...)

前往app查看评论内容

#NBTXR3#

2018年欧洲肿瘤内科学会：NBTXR3在软组织肉瘤中的阳性结果

2019-03-07

科室
- - 订阅+
  - 更多科室
工具
服务